Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Pressure Sore
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the efficacy of nitric oxide gel for pressure sore recovery.
| Condition | Intervention | Phase |
|---|---|---|
|
Pressure Ulcer |
Drug: Nitric Oxide Drug: placebo |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
| Official Title: | A Randomized, Double-blind, Placebo-controlled Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Pressure Sore |
- Pressure ulcer stage assessment after the endpoint of intervention period [ Time Frame: 12 weeks ] [ Designated as safety issue: Yes ]
- The secondary efficacy end point will be pressure sore scale assessment of improvement. [ Time Frame: 12 weeks ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 40 |
| Study Start Date: | July 2012 |
| Estimated Study Completion Date: | July 2013 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: Nitric oxide gel |
Drug: Nitric Oxide
Nitric Oxide Gel, once or twice per day, 12weeks
|
| Placebo Comparator: placebo |
Drug: placebo
placebo Gel, once or twice per day, 12weeks
|
Detailed Description:
Pressure sore is a common problem for patient with bed-ridden. The care of pressure sore cost many social and medical resource, and also effect the quality of life of patients. Current principles of treatment of pressure sore include adequate pain control, optimizing nutritional status, pressure relief, wound cleaning and dressing, infection control and surgical intervention if needed. Wound dressings should be based on wound characteristics. However, for improving wound healing, different dressing materials were developed.
There are increased evidences implicate nitric oxide (NO) synthesis plays an important role in the process of wound healing. Nitric oxide involve in angiogenesis, mediating inflammatory process, cell proliferation and collagen disposition, then improving wound healing. One study used topic NO-gel to mice with second degree burn wound, and found that the NO gel had the potential to enhance burn wound healing by regulation of many cellular processes in the skin. Based on the findings, the investigators hypothesize that NO gel could be used as an alternative method for pressure sore dressing to enhance wound healing.
This is a 12-week study. The investigators plan to enroll 40 subjects. The run-in period is set for screening based on inclusion and exclusion criteria. Baseline data including demographic profiles, medical history and current medications will be obtained, followed by an intact pressure sore inspection. Pressure ulcer stage (developed by NPAUP) , Pressure Ulcer Scale for Healing(PUSH) and Pressure Sore Status Tool(PSST) will be recorded before randomization. Baseline photograph of pressure sore will be taken .
During the treatment phase, a NO gel or placebo gel will be administered on the pressure sore wound by caregiver once or twice daily (decided by doctor according to clinical condition) after standard wound cleaning with normal saline. During the treatment period, the study subjects will be followed- up every 2 weeks to record the wound condition and any side effect. The investigators will use stage, PUSH and PSST, and take serial photograph to monitor wound condition.
Eligibility| Ages Eligible for Study: | 40 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Subjects who live in nursing home
- Clinical diagnosis of pressure sore > grade II(grade developed by NPAUP)
- without acute illness required hospitalization
- able to understanding and signed the Inform Consent Form after detailed description of the treatment and potential risks and benefits
Exclusion Criteria:
- diagnosis of cancer and still on active therapies
- on other medications with pharmacological actions may lead to excessive formation of nitric oxide, or may accentuate drug effects due to excessive formation of nitric oxide
- with systemic infection and need systemic antibiotics
- pressure sore local infection and need topic antibiotic(for pressure sore wound)
- with any known allergic reaction to any ingredient in the 2 gel prescriptions
- Subjects who have been enrolled into any other clinical study in the preceding 3 months prior to randomization
Contacts and Locations| Contact: Chiu-Shong Liu, MD.MSc. | 886-975681842 | liucs@ms14.hinet.net |
| Taiwan | |
| China Medical University Hospital | Recruiting |
| Taichung, Taiwan, 404 | |
| Contact: Chih-Hsueh Lin, MD.Msc. 886-4-22052121 ext 4507 d5496@mail.cmuh.org.tw | |
| Principal Investigator: Chih-Hsueh Lin, MD.MSc | |
| Principal Investigator: | Chiu-Shong Liu, M.D. | China Medical University Hospital |
More Information
No publications provided
| Responsible Party: | China Medical University Hospital |
| ClinicalTrials.gov Identifier: | NCT01351493 History of Changes |
| Other Study ID Numbers: | DMR100-IRB-030 |
| Study First Received: | May 9, 2011 |
| Last Updated: | July 10, 2012 |
| Health Authority: | Taiwan: Department of Health |
Keywords provided by China Medical University Hospital:
|
pressure sore nitric oxide |
Additional relevant MeSH terms:
|
Pressure Ulcer Ulcer Skin Ulcer Skin Diseases Pathologic Processes Nitric Oxide Bronchodilator Agents Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Pharmacologic Actions |
Anti-Asthmatic Agents Respiratory System Agents Therapeutic Uses Free Radical Scavengers Antioxidants Molecular Mechanisms of Pharmacological Action Neurotransmitter Agents Endothelium-Dependent Relaxing Factors Vasodilator Agents Cardiovascular Agents Protective Agents |
ClinicalTrials.gov processed this record on June 13, 2013